Pitfalls of positron emission tomography for assessing relapse in Hodgkin's disease: a case report.
FDG-PET imaging is more frequently being used to stage malignant Lymphoma and monitor response to therapy. However, FDG-PET is not a tumor specific substance and increased accumulation may be seen in a variety of benign entities, our case exemplifies this problem and underline the importance of a biopsy.
Pitini
Vincenzo
V
Department of 1Oncology, University of Messina, Italy. pitini@ciaoweb.it
Navarra
Giuseppe
G
Cavallari
Vittorio
V
Arrigo
Carmela
C
Naro
Claudia
C
Altavilla
Giuseppe
G
D000075202:Contraindications; D019788:Fluorodeoxyglucose F18; D006689:Hodgkin Disease / Q000473:pathology*; D006801:Humans; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography / Q000379:methods; D019275:Radiopharmaceuticals; D012008:Recurrence
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18